UK markets closed

Moleculin Biotech, Inc. (MBRX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.02-0.11 (-2.14%)
At close: 04:00PM EDT
5.15 +0.13 (+2.59%)
After hours: 04:21PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
19,487
19,487
18,968
14,418
12,757
Selling general and administrative
10,017
10,017
11,542
8,386
6,785
Total operating expenses
29,631
29,631
30,640
22,968
19,742
Operating income or loss
-29,631
-29,631
-30,640
-22,968
-19,742
Total other income/expenses net
-1,506
-1,506
1,375
6,768
2,374
Income before tax
-29,769
-29,769
-29,025
-15,894
-17,355
Income tax expense
-
-
-
-
0
Income from continuing operations
-29,769
-29,769
-29,025
-15,894
-17,355
Net income
-29,769
-29,769
-29,025
-15,894
-17,355
Net income available to common shareholders
-29,769
-29,769
-29,025
-15,894
-17,355
Basic EPS
-0.89
-
-15.30
-8.85
-26.40
Diluted EPS
-0.89
-
-15.30
-8.85
-26.40
Basic average shares
29,222
-
1,897
1,792
656.379
Diluted average shares
29,222
-
1,897
1,792
656.379